The clathrin assembly protein AP180 regulates the generation of amyloid-β peptide

Biochemical and Biophysical Research Communications

Volumn 385, Issue 2, 2009, Pages 247-250

  Wu, Fangbai ^a   Matsuoka, Yasuji ^b   Mattson, Mark P ^a   Yao, Pamela J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; AP180; APP; CALM; Clathrin assembly protein; Neuron

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; AP180 PROTEIN; CLATHRIN ASSEMBLY LYMPHOID MYELOID PROTEIN; CLATHRIN ASSEMBLY PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; BRAIN NERVE CELL; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RNA INTERFERENCE;

AMYLOID BETA-PROTEIN; CELL LINE, TUMOR; CLATHRIN; GENE KNOCKDOWN TECHNIQUES; HUMANS; MONOMERIC CLATHRIN ASSEMBLY PROTEINS; NEURONS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RNA INTERFERENCE;

EID: 67349286896     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.05.050     Document Type: Article

References (28)

1. Mattson M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77 (1997) 1081-1132
2. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
3. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
4. Small S.A., and Gandy S. Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron 52 (2006) 15-31
5. Rogaeva E., Meng Y., Lee J.H., Gu Y., Kawarai T., Zou F., Katayama T., Baldwin C.T., Cheng R., Hasegawa H., Chen F., Shibata N., Lunetta K.L., Pardossi-Piquard R., Bohm C., Wakutani Y., Cupples L.A., Cuenco K.T., Green R.C., Pinessi L., Rainero I., Sorbi S., Bruni A., Duara R., Friedland R.P., Inzelberg R., Hampe W., Bujo H., Song Y.Q., Andersen O.M., Willnow T.E., Graff-Radford N., Petersen R.C., Dickson D., Der S.D., Fraser P.E., Schmitt-Ulms G., Younkin S., Mayeux R., Farrer L.A., and St George-Hyslop P. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39 (2007) 168-177
6. Schneider A., Rajendran L., Honsho M., Gralle M., Donnert G., Wouters F., Hell S.W., and Simons M. Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons. J. Neurosci. 28 (2008) 2874-2882
7. Schöbel S., Neumann S., Hertweck M., Dislich B., Kuhn P.H., Kremmer E., Seed B., Baumeister R., Haass C., and Lichtenthaler S.F. A novel sorting nexin modulates endocytic trafficking and alpha-secretase cleavage of the amyloid precursor protein. J. Biol. Chem. 283 (2008) 14257-14268
8. Kyriazis G.A., Wei Z., Vandermey M., Jo D.G., Xin O., Mattson M.P., and Chan S.L. Numb endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoform-dependent manner: implications for Alzheimer disease pathogenesis. J. Biol. Chem. 283 (2008) 25492-25502
9. Cirrito J.R., Kang J.E., Lee J., Stewart F.R., Verges D.K., Silverio L.M., Bu G., Mennerick S., and Holtzman D.M. Endocytosis is required for synaptic activity- dependent release of amyloid-beta in vivo. Neuron 58 (2008) 42-51
10. F. Wu, P.J. Yao, Clathrin-mediated endocytosis and Alzheimer's disease: an update. Ageing Res. Rev. in press.
11. Ahle S., and Ungewickell E. Purification and properties of a new clathrin assembly protein. EMBO J. 5 (1986) 3143-3149
12. Ye W., and Lafer E.M. Bacterially expressed F1-20/AP-3 assembles clathrin into cages with a narrow size distribution: implications for the regulation of quantal size during neurotransmission. J. Neurosci. 41 (1995) 15-26
13. Dreyling M.H., Martinez-Climent J.A., Zheng M., Mao J., Rowley J.D., and Bohlander S.K. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc. Natl. Acad. Sci. USA 93 (1996) 4804-4809
14. Morgan J.R., Zhao X., Womack M., Prasad K., Augustine G.J., and Lafer E.M. A role for the clathrin assembly domain of AP180 in synaptic vesicle endocytosis. J. Neurosci. 19 (1999) 10201-10212
15. Tebar F., Bohlander S.K., and Sorkin A. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, Interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol. Biol. Cell 10 (1999) 2687-2702
16. Meyerholz A., Hinricchsen L., Groos S., Esk P.C., Brandes G., and Ungewickell E.J. Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation. Traffic 6 (2005) 1225-1234
17. Sousa R., Tannery N.H., Zhou S., and Lafer L.M. Characterization of a novel synapse specific protein. I. Developmental expression and cellular localization of the F1-20 protein and mRNA. J. Neurosci. 12 (1992) 2130-2143
18. Yao P.J., Petralia R.S., Bushlin I., Wang Y., and Furukawa K. Synaptic distribution of the endocytic accessory proteins AP180 and CALM. J. Comp. Neurol. 481 (2005) 58-69
19. Bushlin I., Petralia R.S., Wu F., Harel A., Mughal M.R., Mattson M.P., and Yao P.J. Clathrin assembly protein AP180 and CALM differentially control axogenesis and dendrite outgrowth in embryonic hippocampal neurons. J. Neurosci. 28 (2008) 10257-10271
20. Takeda K., Araki W., and Tabira T. Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur. J. Neurosci. 19 (2004) 258-264
21. Harel A., Wu F., Mattson M.P., Morris C.M., and Yao P.J. Evidence for CALM in directing VAMP2 trafficking. Traffic 9 (2008) 417-429
22. Hirata-Fukae C., Sidahmed E.H., Gooskens T.P., Aisen P.S., Dewachter I., Devijver H., Van Leuven F., and Matsuoka Y. Beta-site amyloid precursor protein- cleaving enzyme-1 (BACE1)-mediated changes of endogenous amyloid beta in wild-type and transgenic mice in vivo. Neurosci. Lett. 435 (2008) 186-189
23. Sharp P.A. RNA interference-2001. Genes Dev. 15 (2001) 485-490
24. Birmingham A., Anderson E., Sullivan K., Reynolds A., Boese Q., Leake D., Karpilow J., and Khvorova A. A protocol for designing siRNAs with high functionality and specificity. Nat. Protoc. 2 (2007) 2068-2078
25. Hilbich C., Mönning U., Grund C., Masters C.L., and Beyreuther K. Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J. Biol. Chem. 268 (1993) 26571-26577
26. Yao P.J., and Coleman P.D. Reduction of O-linked N-acetylglucosamine- modified assembly protein-3 in Alzheimer's disease. J. Neurosci. 18 (1998) 2399-2411
27. Yao P.J., Morsch R., Callahan L.M., and Coleman P.D. Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry. Neuroscience 94 (1999) 389-394
28. Petralia R.S., and Yao P.J. AP180 and CALM in the developing hippocampus: expression at the nascent synapse and localization to trafficking organelles. J. Comp. Neurol. 504 (2007) 314-327